Lululemon Cuts Earnings Forecast, Joins DocuSign, Samsara And Other Big Stocks Moving Lower In Friday's Pre-Market Session
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Jun 06 2025
0mins
Should l Buy DOCU?
Source: Benzinga
Stock Market Overview: U.S. stock futures are up, with Dow futures increasing by about 100 points; however, several companies, including Lululemon and Vera Therapeutics, saw significant declines in pre-market trading due to lowered earnings forecasts or disappointing results.
Company Performance Highlights: Lululemon's shares dropped 20.9% after cutting its FY25 EPS guidance, while DocuSign's shares fell despite better-than-expected results, indicating mixed reactions to earnings reports among various stocks.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy DOCU?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on DOCU
Wall Street analysts forecast DOCU stock price to rise
16 Analyst Rating
3 Buy
13 Hold
0 Sell
Hold
Current: 47.710
Low
70.00
Averages
80.23
High
105.00
Current: 47.710
Low
70.00
Averages
80.23
High
105.00
About DOCU
DocuSign, Inc. provides intelligent agreement management (IAM) platform an eSignature solution, and contract lifecycle management (CLM) solution - allow organizations to increase productivity, accelerate contract review cycles, and transform agreement data into insights and actions. The Company’s IAM platform automates agreement workflows, uncovers actionable insights, and leverages artificial intelligence (AI) capabilities, enabling organizations to create, commit, and manage agreements virtually. Its products include eSignature, CLM, IAM Apps, and Add-on Products. Its Add-on Products include Payments to collect payments along with signed agreements; Identity and standards-based signature for enhanced signer-identification and signatures with digital certification; Notary for remote online notarization; Monitor for advanced analytics; Gen for Salesforce for automated agreement generation within Salesforce, among others.
About the author

Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
- Financial Health Outlook: Docusign's net debt to adjusted EBITDAR ratio is expected to drop to approximately 0.9x in Q1 from 3.2x in Q4, indicating a significant improvement in financial health that could enhance future growth potential.
- Optimistic Growth Prospects: Analysts anticipate Klaviyo will achieve nearly 30% growth, reflecting the resilience of modern Customer Engagement Platforms in the new AI landscape, thereby reinforcing its market position.
- Profitability Enhancement: Paycom's headcount reduction is expected to meaningfully boost EBITDA, providing room for the company to exceed profitability expectations, showcasing its competitive advantage.
- Market Environment Challenges: Despite a challenging macro environment, Barclays analysts emphasize the need to focus on company-specific narratives, with Docusign, Klaviyo, and Paycom highlighted as key stocks to watch in the upcoming earnings season.
See More
- ROI Enhancement: The report from Docusign and Deloitte reveals that companies utilizing AI-driven agreement management report nearly 30% higher ROI compared to those that do not, indicating the significant potential of AI in enhancing business efficiency.
- Efficiency and Cost Savings: The study shows that organizations leveraging AI agreement workflows achieve an average of 36% efficiency gains and 29% cost savings, demonstrating that AI can accelerate processes while reducing labor costs, thereby enhancing competitive advantage.
- Contract Management Transformation: Approximately 65% of organizations use four or more tools to manage agreements, leading to process friction, while integrating AI insights allows businesses to improve decision-making quality early in the contract management process, optimizing the entire workflow.
- Cross-Department Collaboration Improvement: Docusign's Intelligent Agreement Management platform enables legal, sales, and HR departments to save 37%, 43%, and 45% of their time respectively, highlighting that cross-department collaboration and data integration are key to achieving high ROI.
See More
- TSMC's Strong Performance: TSMC reported a 35% year-over-year revenue increase in Q1, with March alone seeing a 45% surge, indicating robust demand in the semiconductor market that could help Nvidia's stock break free and join the ranks of memory stocks.
- Intel Price Target Raised: Melius Research raised Intel's price target from $58 to $75 while maintaining a buy rating, reflecting optimism about its partnerships with Elon Musk's Terafab project and Google, with CEO Lip-Bu Tan's leadership being widely acknowledged.
- UBS Downgrades ServiceNow: UBS downgraded ServiceNow from buy to hold, citing weakened confidence in its ability to withstand AI disruption, despite the stock already being down 41% year-to-date, indicating a significant shift in analyst sentiment.
- Southern Company Price Target Increased: Citi raised Southern Company's price target from $107 to $114, as analysts see growth potential amid the surge in demand for electricity driven by AI data centers, maintaining a buy rating and reflecting optimism in the utility sector.
See More

- AI Contract Review Assistant: Docusign's newly launched AI contract review assistant, powered by the Iris engine, aims to accelerate the contract review process for legal teams by analyzing agreements and highlighting key terms and risks, thereby enhancing overall business efficiency.
- Time Reduction in Reviews: The assistant provides quick answers to legal teams, such as “Does this contract auto-renew?”, linking directly to relevant terms in the contract, significantly reducing the time spent on manual searches and improving workflow efficiency.
- Enhanced Editing Efficiency: The assistant can suggest redlines, generate edits, and draft new contract language, making the review process more efficient, allowing legal teams to focus more on negotiations and risk management.
- Optimized Agreement Management: According to Deloitte's 2025 report, over 70% of legal leaders believe agreement management tools improve caseloads and legal outcomes; Docusign's AI contract review assistant addresses this need by facilitating more efficient workflows in contract creation, review, signing, and management.
See More
- Industry Recognition: Docusign has been named one of Fast Company's Most Innovative Companies of 2026, highlighting its leadership in contract management and further solidifying its market influence.
- Intelligent Agreement Management Platform: The launch of Docusign's Intelligent Agreement Management (IAM) platform combines enterprise-grade AI with end-to-end workflow automation, enhancing contract management efficiency while transforming static contracts into dynamic business intelligence that aids faster decision-making.
- Business Process Integration: The IAM platform connects agreements directly to tools like CRM, ERP, and HR, breaking down fragmented processes to achieve end-to-end workflows, thereby improving operational efficiency across the enterprise.
- Defining a New Category: By unifying every step of the agreement process, Docusign is shifting businesses from merely managing documents to driving business outcomes, unlocking potential for speed, alignment, and growth, and further propelling industry transformation.
See More
- Earnings Beat Expectations: Docusign (DOCU) reported Q4 fiscal 2026 results that exceeded market expectations, yet the full-year revenue growth outlook of 7% remains below the long-term target of 10%, leaving investor sentiment unchanged.
- Neutral Ratings Maintained: UBS analysts lowered Docusign's price target from $75 to $54, asserting that while year-end ARR growth shows slight acceleration, the stable 7% total revenue growth is unlikely to shift market perceptions.
- Buyback Program as a Catalyst: Bank of America highlighted Docusign's $2 billion share buyback program as a potential catalyst for stock price movement, although the FY27 ARR growth guidance of 8.5% raises questions about the level of conservatism in the projections.
- Strong IAM Performance: Wolfe Research noted that Docusign's Intelligent Agreement Management (IAM) accounted for 10.8% of ARR, with FY27 guidance suggesting an 80% growth in IAM ARR, indicating robust expansion and retention capabilities.
See More








